Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

35.55
Delayed Data
As of May 25
 +0.20 / +0.57%
Today’s Change
26.95
Today|||52-Week Range
51.10
-22.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues197.7M249.0M276.4M286.6M
 
 
 
 
 
Cost of Goods Sold67.4M60.4M97.2M74.1M
 
 
 
 
 
Depreciation And Amortization10.0M11.5M12.9M13.8M
 
 
 
 
 
 
Operating ExpensesGross Income120.2M177.2M166.3M198.7M
 
 
 
 
 
General Expenses125.4M167.7M191.2M211.7M
 
 
 
 
 
Research And Development18.7M28.7M45.7M57.3M
 
 
 
 
 
Total Operating Expenses202.8M239.5M301.3M299.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.2M9.5M-24.9M-13.0M
 
 
 
 
 
Extraordinary Charge0.00-52.0K-7.1M-15.7M
 
 
 
 
Interest Expense On Debt9.0M8.6M8.6M19.1M
 
 
 
 
 
Other Expenses-159.0K-165.0K-82.0K167.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.5M2.1M-37.8M-42.5M
 
 
 
 
 
Income Taxes-173.0K-264.0K-105.0K-140.0K
 
 
 
 
 
Net Income-13.7M1.9M-37.9M-42.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS35.3M36.5M37.2M39.8M
 
 
 
 
 
Shares To Calculate EPS Diluted35.3M41.3M37.2M39.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.39$0.04-$1.02-$1.07
 
 
 
 
 
EPS Diluted-$0.39$0.04-$1.02-$1.07